Characterization of THSD7A-antibodies not binding to glomerular THSD7A in a patient with diabetes mellitus but no membranous nephropathy
Abstract Membranous nephropathy (MN) is an autoimmune disease caused by autoantibodies against the podocyte antigens phospholipase A2 receptor 1 (PLA2R1) and thrombospondin type 1 domain containing protein 7A (THSD7A) in 80% and 2–3% of patients, respectively. THSD7A antibodies are considered to be...
Guardado en:
Autores principales: | Linda Reinhard, Cindy Thomas, Maya Machalitza, Erik Lattwein, Lothar S. Weiss, Jan Vitu, Thorsten Wiech, Rolf A. K. Stahl, Elion Hoxha |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7cb5f316a0974a24915ddcfd77d0a653 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Soluble THSD7A is an N-glycoprotein that promotes endothelial cell migration and tube formation in angiogenesis.
por: Meng-Wei Kuo, et al.
Publicado: (2011) -
Kidney transplantation outcomes in patients with IgA nephropathy and other glomerular and non-glomerular primary diseases in the new era of immunosuppression.
por: Sophia Lionaki, et al.
Publicado: (2021) -
A haplotype in CFH family genes confers high risk of rare glomerular nephropathies
por: Yin Ding, et al.
Publicado: (2017) -
Sprawozdanie z konferencji „Archiwa, biblioteki, kolekcje na terenie Galicji 1772-1918”, Przemyśl 7 maja 2019
por: Arkadiusz S. Więch
Publicado: (2019) -
Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression
por: Xiaofei An, et al.
Publicado: (2017)